首页> 外文期刊>Bangladesh Pharmaceutical Journal >Bioactivities of Colocasia affinis Schott and Profiling of its Bioactive Polyphenols by HPLC-DAD
【24h】

Bioactivities of Colocasia affinis Schott and Profiling of its Bioactive Polyphenols by HPLC-DAD

机译:Colocasia Affinis的生物活性Schott和HPLC-Dad的生物活性多酚的分析

获取原文
       

摘要

Traditional medicines including Ayurveda, Unani have been used as therapeutics in the Indian subcontinent since 5000 BC. Because of the abundance of secondary metabolites, medicinal plants are becoming priceless natural resources for better drug development. Till date almost no ethnopharmacological evidences were available on Colocasia genus except Colocasia esculenta. As a part of our continuing assessment of evidence based use of traditional medicine, we have identified bioactive polyphenols in the ethanolic leaves extract of Colocasia affinis Schott using HPLC-DAD method and evaluated its anti-allergy, anti-inflammatory and anti-diabetic potentials for the first time. Chromatographic investigation showed the presence of p-coumaric acid, trans-ferulic acid, rosmarinic acid, myricetin and kaempferol in the leaves extract. Pharmacological profile exploration demonstrated its anti-inflammatory activity at a dose of 250- and 500-mg/kg in xylene-induced ear edema in mice. The extract significantly reduced the allergy like symptoms such as sneezing, scratching, rhinorrhea, redness and swelling in Tolune diisocyanate (TDI) sensitized allergy model mice at 250- and 500-mg/kg doses. Besides, the extract also exhibited reduction in the level of neutrophils, lymphocytes and eosinophils in a dose dependent manner in the experimental animal. The extract also confirmed reduction of blood glucose levels in the experimental mice at a dose of 250- and 500-mg/kg. Therefore, it is evident that C. affinis demonstrated possesses medicinal values through its anti-inflammatory, anti-allergic and anti-hyperglycaemic potentials.
机译:包括Ayurveda,Unani在内的传统药物已被用作自5000年以来的印度次大陆的治疗方法。由于次级代谢物丰富,药用植物正在成为更好的药物开发的自然资源。迄今为止,除了Colocasia Esculenta外,Colocasia Genus几乎没有任何民营医药证据。作为我们持续评估的传统医学循证使用的一部分,我们已经使用HPLC-DAD方法鉴定了乙醇叶片中的乙醇叶提取物中的生物活性多酚,并评估其抗过敏,抗炎和抗糖尿病潜力第一次。色谱查显示表现出对叶子提取物中的p-香豆酸,转铁酸,rosmarinic酸,霉菌素和kaempferol。药理概况勘探在小鼠中以250-和500mg / kg的剂量的剂量显示其抗炎活性。提取物显着降低了症状,如打喷嚏,刮擦,鼻塞,发红和溶胀等症状,在250-和500mg / kg剂量下醇酸二异氰酸酯(TDI)敏化过敏模型小鼠。此外,提取物还以实验动物剂量依赖性方式表现出嗜中性粒细胞,淋巴细胞和嗜酸性粒细胞的水平降低。提取物还在250-和500mg / kg的剂量下证实了实验小鼠中的血糖水平的降低。因此,显然,C. Affinis证明通过其抗炎,抗过敏和抗高血糖潜力具有药物价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号